Xvivo Perfusion AB (publ) (XVIPY)
OTCMKTS
· Delayed Price · Currency is USD
11.45
-0.80 (-6.53%)
Oct 25, 2024, 2:26 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Thoracic | 384.36M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Thoracic Growth | 29.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Abdominal | 134.04M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Abdominal Growth | 89.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services | 79.14M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services Growth | 64.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| All Business except Durable Goods | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| All Business except Durable Goods Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Durable Goods | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Durable Goods Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| United States | 308.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 37.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Excluding Sweden, Netherlands and Italy | 128.28M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Excluding Sweden, Netherlands and Italy Growth | 32.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Italy | 58.93M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Italy Growth | 174.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia/Pacific and Oceania | 42.18M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia/Pacific and Oceania Growth | 124.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Netherlands | 30.22M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Netherlands Growth | 16.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North and South America, Excluding the United States | 25.62M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North and South America, Excluding the United States Growth | 0.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sweden | 4.22M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sweden Growth | 152.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|